Longitude Capital Partners Iii's Net Worth

Longitude Capital Partners Iii's net worth is estimated to be at least $49,778,507.00 as of 05/23/2024. CoreStreet's estimation of Longitude Capital Partners Iii's net worth is based on their sale of stock and current holding of stock.

Longitude Capital Partners Iii is Major Shareholder at Inozyme Pharma Inc. They have executed at least 8 trades of stock as per SEC Form 4 filings. Their most recent trade was for 1,355,000 units of INZY stock on 04/19/2022. Their biggest sale was on 08/28/2020 when they sold 3,496 units of Molecular Templates Inc stock for $37,582.00. They typically trade 2 times per year.

Total value of insider buys:
  • $49,740,925.00
Total value of insider sells:
  • $37,582.00
Most recent insider trade:
  • April 19, 2022

Longitude Capital Partners Iii's Insider Trading History

Inozyme Pharma IncTitleAmountPriceTypeTotal Value
April 19, 2022
Major Shareholder1,355,000$3.69Buy$4,999,950.00
July 28, 2020
Major Shareholder625,000$16.00Buy$10,000,000.00
Sierra Oncology IncTitleAmountPriceTypeTotal Value
Feb. 2, 2022
Major Shareholder175,000$27.00Buy$4,725,000.00
Talaris Therapeutics IncTitleAmountPriceTypeTotal Value
May 11, 2021
Major Shareholder235,000$17.00Buy$3,995,000.00
Molecular Templates IncTitleAmountPriceTypeTotal Value
Aug. 28, 2020
Major Shareholder3,496$10.75Sell$37,582.00
Nov. 25, 2019
Major Shareholder937,000$8.00Buy$7,496,000.00
89bio IncTitleAmountPriceTypeTotal Value
July 10, 2020
Major Shareholder109,090$27.50Buy$2,999,975.00
Nov. 11, 2019
Major Shareholder575,000$27.00Buy$15,525,000.00